These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11414589)

  • 1. Estimation of a secondary parameter in a group sequential clinical trial.
    Gorfine M
    Biometrics; 2001 Jun; 57(2):589-97. PubMed ID: 11414589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivor function estimators under group sequential monitoring based on the logrank statistic.
    Gorfine M
    Lifetime Data Anal; 2003 Jun; 9(2):175-93. PubMed ID: 12735495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computation of the uniform minimum variance unbiased estimator of a normal mean following a group sequential trial.
    Emerson SS
    Comput Biomed Res; 1993 Feb; 26(1):68-73. PubMed ID: 8444028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a continuous stopping boundary from an alpha spending function.
    Betensky RA
    Biometrics; 1998 Sep; 54(3):1061-71. PubMed ID: 9750252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.
    Shimura M; Maruo K; Gosho M
    Pharm Stat; 2018 Sep; 17(5):400-413. PubMed ID: 29687592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
    Furberg CD; Byington RP
    Circulation; 1983 Jun; 67(6 Pt 2):I98-101. PubMed ID: 6133654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Beta Blocker Heart Attack Trial: recruitment experience.
    Goldstein S; Byington R
    Control Clin Trials; 1987 Dec; 8(4 Suppl):79S-85S. PubMed ID: 2894282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta-blocker heart attack trial.
    Furberg C
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):3S-5S. PubMed ID: 6126206
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Publicity on the beta-blocker heart attack trial (continued).
    Frommer PL
    N Engl J Med; 1982 Jun; 306(25):1553-4. PubMed ID: 6123081
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-adrenergic blocking agents after myocardial infarction: an undocumented need in patients at lowest risk.
    Griggs TR; Wagner GS; Gettes LS
    J Am Coll Cardiol; 1983 Jun; 1(6):1530-3. PubMed ID: 6133891
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
    Staessen J; Bulpitt C; Cattaert A; Fagard R; Vanhees L; Amery A
    Am Heart J; 1982 Dec; 104(6):1395-9. PubMed ID: 6128918
    [No Abstract]   [Full Text] [Related]  

  • 18. Statistical aspects of early termination in the beta-blocker heart attack trial.
    DeMets DL; Hardy R; Friedman LM; Lan KK
    Control Clin Trials; 1984 Dec; 5(4):362-72. PubMed ID: 6151482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point estimation following a two-stage group sequential trial.
    Grayling MJ; Wason JM
    Stat Methods Med Res; 2023 Feb; 32(2):287-304. PubMed ID: 36384365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation After a Group Sequential Trial.
    Milanzi E; Molenberghs G; Alonso A; Kenward MG; Tsiatis AA; Davidian M; Verbeke G
    Stat Biosci; 2015 Oct; 7(2):187-205. PubMed ID: 26478751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.